1st ALS patient enrolled in MN-166 expanded access program - ALS News Today
The first ALS patient has been enrolled in an NIH-funded expanded access program trial evaluating MN-166 (ibudilast).
Search Group
Share To
Comments
About Screade
Screade® Inc. version f7eb701, copyright 2016 - 2025
Blocked Users
Customize Dark Theme
Forgot your password?
Forgot your password?
Invite your friends
Please type emails of people you want to invite, we will send them invitation email on your behalf. Separate emails with comma if you want to invite multiple friends.
Comments